Doudou Wen
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RFC5 and STAT3 form a transcriptional complex to drive NSCLC progression via c-Myc.
Journal: iScience
Published: December 09, 2025
RAB40C recruiting TRIM21 facilitates the progression of hepatocellular carcinoma by stabilizing EGFR.
Journal: Cell communication and signaling : CCS
Published: July 26, 2025
ALDH3A2 targets arachidonic acid to promote cell metastasis in TNBC via AMPK/m-TOR signaling pathway.
Journal: Breast cancer research : BCR
Published: April 03, 2025
Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma.
Journal: The Journal of pharmacy and pharmacology
Published: November 20, 2024
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: February 18, 2024
Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Journal: Gene
Published: December 13, 2023
Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 13, 2023
A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: February 14, 2023
Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway.
Journal: Heliyon
Published: February 09, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026